Hologic Inc at Evercore ISI HealthCONx Conference Transcript
Joining us this afternoon. I'm Vijay Kumar, the med tech and life sciences analyst at Evercore. A pleasure to have with us Hologic. From the company, we have CFO Karleen Oberton. And I think from Investor Relations, we have Ryan Simon floating around, I think, in the hallway.
Questions & Answers
But maybe Karleen, starting with you, I mean, fiscal '23 was really, really strong for Hologic. And in the guide -- I think when I look at your fiscal '24, excluding days, I think 5% to 8% is above your LRP rate. Comps were tougher despite that the guidance is pretty solid. And I think people are still trying to struggle with like the drivers, what has caused this turnaround rate? Let's start with molecular
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
